These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7885328)

  • 1. [Antibody engineering].
    Deev SM; Polianovskiĭ OL
    Mol Biol (Mosk); 1994; 28(6):1272-82. PubMed ID: 7885328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protein engineering of immunoglobulin molecules by recombinant DNA technology].
    Koga H; Watanabe T
    Tanpakushitsu Kakusan Koso; 1992 Feb; 37(3 Suppl):322-34. PubMed ID: 1549711
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies from Escherichia coli.
    Plückthun A
    Nature; 1990 Oct; 347(6292):497-8. PubMed ID: 2215666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering antibodies for biosensor technologies.
    Goodchild S; Love T; Hopkins N; Mayers C
    Adv Appl Microbiol; 2006; 58():185-226. PubMed ID: 16509447
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody production without animals.
    Stadler BM
    Dev Biol Stand; 1999; 101():45-8. PubMed ID: 10566774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of 1116NS19.9 heavy and light chain cDNAs and expression of antibody fragments in Escherichia coli.
    Tonge DW; Hennam JF; Greene AR; Lee ID; Edge MD
    Year Immunol; 1993; 7():56-62. PubMed ID: 8372513
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure and function of chimaeric antibodies.
    Ahmed N
    Bioessays; 1987 Apr; 6(4):175-7. PubMed ID: 3593328
    [No Abstract]   [Full Text] [Related]  

  • 8. Cloning, expression and characterisation of a single-chain Fv antibody fragment against domoic acid in Escherichia coli.
    Hu X; O'Dwyer R; Wall JG
    J Biotechnol; 2005 Oct; 120(1):38-45. PubMed ID: 16019098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering antibodies for clinical applications.
    Jain M; Kamal N; Batra SK
    Trends Biotechnol; 2007 Jul; 25(7):307-16. PubMed ID: 17512622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
    Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
    Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody production with yeasts and filamentous fungi: on the road to large scale?
    Gasser B; Mattanovich D
    Biotechnol Lett; 2007 Feb; 29(2):201-12. PubMed ID: 17120087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic engineering of antibodies].
    Liu YF; Fu Y
    Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):5-6. PubMed ID: 12846217
    [No Abstract]   [Full Text] [Related]  

  • 13. [Construction and expression of single chain Fv antibody against human bladder carcinoma].
    Zhang M; Yu L; Huang H
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):792-5. PubMed ID: 16201198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Fab' fragments for efficient F(ab)2 formation in Escherichia coli and for improved in vivo stability.
    Rodrigues ML; Snedecor B; Chen C; Wong WL; Garg S; Blank GS; Maneval D; Carter P
    J Immunol; 1993 Dec; 151(12):6954-61. PubMed ID: 7903100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designer mice: the production of human antibody repertoires in transgenic animals.
    Brüggemann M; Davies NP; Rosewell IR
    Year Immunol; 1993; 7():33-40. PubMed ID: 8372511
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes of primary sequence and secondary structure proximal to the 5' end of the stop codon substantially increases the expression of the variable region of an antibody in E. coli.
    Qin W; Feng J; Li Y; Lin Z; Shen B
    Biotechnol Lett; 2005 Jan; 27(2):131-4. PubMed ID: 15703877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved growth response of antibody/receptor chimera attained by the engineering of transmembrane domain.
    Kawahara M; Ogo Y; Ueda H; Nagamune T
    Protein Eng Des Sel; 2004 Oct; 17(10):715-9. PubMed ID: 15548567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of recombinant antibody fragments to methamphetamine by anchored periplasmic expression.
    Harvey BR; Shanafelt AB; Baburina I; Hui R; Vitone S; Iverson BL; Georgiou G
    J Immunol Methods; 2006 Jan; 308(1-2):43-52. PubMed ID: 16337958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast selection of antibodies without antigen purification: adaptation of the protein fragment complementation assay to select antigen-antibody pairs.
    Mössner E; Koch H; Plückthun A
    J Mol Biol; 2001 Apr; 308(2):115-22. PubMed ID: 11327756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level expression of proteins in Escherichia coli using a pETCX10 expression system.
    Shoju H; Sueyoshi N; Kameshita I
    Anal Biochem; 2006 Jun; 353(2):290-2. PubMed ID: 16564486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.